Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 344 followers
Latest posts
Last updated about 6 hours ago
GSK’s Hansoh-partnered ADC lays down marker for lung cancer scrap with Merck
about 6 hours ago
GSK’s risvutatug rezetecan has achieved a median overall survival of 18.5 months...
FDA delays approval decision for Exelixis' tyrosine kinase inhibitor in colorectal cancer
1 day ago
The FDA has delayed its approval decision for Exelixis’ oral kinase inhibitor...
The future of RAS inhibitors
1 day ago
Revolution Medicines recently made history with the approval of its RAS inhibitor...
Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'?
1 day ago
The announcement from Merck & Co. and Moderna last month that their...
Singapore launches biotech-focused Boston hub to build on 'centuries-old bond'
1 day ago
Officials rubbed shoulders with business leaders in a 19th-floor meeting room to...
Chutes & Ladders—Longtime Takeda R&D chief to depart next June
1 day ago
Takeda President of Research and Development Andy Plump, M.D., Ph.D., is leaving...
Scientists boycott American Diabetes Association as fallout of June conference fracas escalates
1 day ago
Following the removal of five scientists from its annual conference in June...
In first interview as FDA oncology chief, Angelo de Claro vows to ‘continue the innovation’ behind OCE legacy
2 days ago
In his first interview after taking the reins of the FDA’s Oncology...
The signal that changes everything: understanding MRD in oncology drug development
2 days ago
Is the cancer truly gone?
Moving NAMs from Progress to Practice: Building the Foundation for Broader Adoption
2 days ago
The future of NAMs depends on more than innovation. Learn how sourcing...
Frazier Life Sciences nets $1.1B in long-running fund aimed at small, midsize biotechs
3 days ago
Frazier Life Sciences (FLS) has stacked up another sizable biotech-focused capital commitment...
Novartis shareholder calls for board overhaul following costly deal setbacks: Reuters
3 days ago
Novartis’ recent dual clinical setbacks have prompted questions from a major shareholder...